News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US FDA Warns VaxGen Over Anthrax Vaccine Promotion


4/4/2006 11:09:29 AM

WASHINGTON, April 4 (Reuters) - VaxGen Inc. (VXGN.PK: Quote, Profile, Research) exaggerated the benefits of its experimental anthrax vaccine at a recent annual meeting on government research, U.S. health regulators said in a warning letter released on Tuesday.


Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES